Mate share price doesn't really tell the full story.
The market cap has fallen from high of $aud62 million to the present $aud 20million due to dilution.
This was an illiquid stock, which added to risk. Previously no to mid thousands of shares would trade per day, Now we see millions of shares traded per day. So the dilution is bad for early holders, but has derisked for buyers down here. Such is early life drug discovery biotech companies. When you have no income stream there will be dilution.
CHM Price at posting:
2.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)